
Solventum Corp company profile
$89.08+0.30%Close 13 Nov 2026
About Solventum Corp
Solventum Corporation is a global healthcare company that develops, manufactures, and commercializes medical and dental products and healthcare software. Its MedSurg segment, which accounted for 57.9% of 2025 total sales, offers negative pressure wound therapy, advanced wound dressings, surgical supplies, sterilization assurance, and temperature management solutions. Dental Solutions, at 16.2% of 2025 total sales, provides dental and orthodontic products including brackets, aligners, and restorative materials. Health Information Systems, at 16.3% of 2025 total sales, supplies healthcare systems with documentation, coding, and revenue cycle software. The company sells principally to hospitals, physicians, and other healthcare providers, with sales in over 90 countries.
A summary of the business section of the company's latest annual report, filed 27 Feb 2026.
Company facts
| Ticker | SOLV · NYSE |
|---|
| Sector | Medical devices |
|---|
| Industry | Health Care Technology |
|---|
| Index | S&P 500 |
|---|
| Fiscal year ends | 31 December |
|---|
| Reporting currency | USD |
|---|
| CIK | 1964738 |
|---|
| Latest annual report | 10-K, filed 27 Feb 2026 |
|---|
Officers and directors
| Name | Role | Shares owned | Latest Form 4 |
|---|
| Bryan Hanson | Chief Executive Officer · Director | 124K · < 1% | Option exercise, 1 Sep 2026 |
|---|
| Wayde McMillan | Chief Financial Officer | 43.5K · < 1% | Shares withheld for tax, 13 May 2026 |
|---|
| Amy Landucci | Chief Information Officer | 37.5K · < 1% | Option exercise, 13 May 2026 |
|---|
| Marcela Kirberger | Chief Legal Affairs Officer | 11.0K · < 1% | Shares withheld for tax, 13 May 2026 |
|---|
| Chris Barry | Executive Vice President | 9.2K · < 1% | Option exercise, 13 May 2025 |
|---|
| Carrie S. Cox | Director | 5.1K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Amy A. Wendell | Director | 5.0K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Elizabeth A. Mily | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Susan D. DeVore | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Shirley Edwards | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Glenn A. Eisenberg | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Dr. Bernard A. Harris Jr. | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Karen J. May | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| John H. Weiland | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Darryl L. Wilson | Director | 3.6K · < 1% | Option exercise, 30 Apr 2026 |
|---|
| Wilcox Mary T | Chief Accounting Officer | — | Option exercise, 13 May 2026 |
|---|
| Harrington Paul S | Chief Supply Chain Officer | — | Option exercise, 13 May 2026 |
|---|
| Gomez Tammy L | Chief Human Resources Officer | — | Shares withheld for tax, 13 May 2026 |
|---|
| ALBAN CARLOS | Director | — | Option exercise, 30 Apr 2026 |
|---|
| Solventum Corp | Chief Legal Affairs Officer | — | Option exercise, 1 Dec 2024 |
|---|
Holdings as the latest proxy statement states them, all forms counted; the latest Form 4 line each filed. People appointed since the proxy are listed from their Form 4 filings.
SOLV in the terminal
The business section of every annual report, officers' holdings and trades, and the company's filings as they arrive.